Potential Agents against Plasma Leakage
Author(s) -
Jeanne Adiwinata Pawitan
Publication year - 2011
Publication title -
isrn pharmacology
Language(s) - English
Resource type - Journals
eISSN - 2090-5173
pISSN - 2090-5165
DOI - 10.5402/2011/975048
Subject(s) - sepsis , microbiology and biotechnology , leakage (economics) , biology , chemistry , pharmacology , immunology , macroeconomics , economics
Shock due to severe plasma leakage may happen in infectious diseases such as severe dengue and sepsis due to various bacterial infections, which may be deleterious and may lead to death. Various substances and proteins are known to modulate the effects of proleakage mediators and counteract the deleterious effect of plasma leakage. Some of the various substances and proteins such as focal adhesion kinase (FAK), the Rho GTPases, protein kinase A, and caveolin-1 have dual actions; therefore they are not suitable for therapy. However, sphingosine 1phosphate and its receptor agonists, Angiopoetin-1, Slit, and Bbeta15–42 may be promising.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom